Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Data Collection of Pediatric Patients With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP) Treated With Caplacizumab

NCT05263193 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT05263193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05263193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Data Collection of Pediatric Patients With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP) Treated With Caplacizumab
Lead sponsor
Sanofi
Phase
Observational
Overall status
Completed
Start date
June 8, 2022
Completion date
October 28, 2022
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune-mediated thrombocytopenic purpura